Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKT1 | P31749 | 1/20 | 0.56 |
| ▸ | HPSE | Q9Y251 | 7/20 | 0.53 |
| ▸ | FGF2 | P09038 | 1/20 | 0.52 |
| ▸ | GBA1 | P04062 | 2/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | IGF2R | P11717 | 4/20 | 0.43 |
| ▸ | TERT | O14746 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18710686 | 1.00 | AKT1 (0.56) | AKT1HPSEFGF2GBA1MAPK1 | |
| SCHEMBL20531001 | 1.00 | AKT1 (0.56) | AKT1HPSEFGF2GBA1MAPK1 | |
| SCHEMBL1392875 | 1.00 | AKT1 (0.56) | AKT1HPSEFGF2GBA1MAPK1 | |
| SCHEMBL13857738 | 1.00 | AKT1 (0.56) | AKT1HPSEFGF2GBA1MAPK1 | |
| SCHEMBL21628176 | 1.00 | AKT1 (0.56) | AKT1HPSEFGF2GBA1MAPK1 | |
| SCHEMBL13857778 | 1.00 | AKT1 (0.56) | AKT1HPSEFGF2GBA1MAPK1 | |
| SCHEMBL13857773 | 1.00 | AKT1 (0.56) | AKT1HPSEFGF2GBA1MAPK1 | |
| SCHEMBL416518 | 1.00 | AKT1 (0.56) | AKT1HPSEFGF2GBA1MAPK1 | |
| SCHEMBL21628177 | 1.00 | AKT1 (0.56) | AKT1HPSEFGF2GBA1MAPK1 | |
| SCHEMBL13858216 | 1.00 | AKT1 (0.56) | AKT1HPSEFGF2GBA1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3386999-B1 | METHOD FOR THE PREPARATION OF A COMPOSITION COMPRISING DERIVATIVES OF ALKYL URONIC ACIDS OF ALKYL GULOSIDE, SAID COMPOSITIONS AND APPLICATIONS THEREOF AS SURFACTANT | ECOLE NAT SUPERIEURE DE CHIMIE (FR) | 2021-01-27 | — | — | EP | disclosed |
| US-10544180-B2 | Process for preparing compositions comprising alkyl(alkyl-glucoside)uronates, said compositions and use thereof as a surfactant | ÉCOLE NATIONALE SUPÉRIEURE DE CHIMIE (FR) | 2020-01-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10544180-B2 | Process for preparing compositions comprising alkyl(alkyl-glucoside)uronates, said compositions and use thereof as a surfactant | UGGT1, UGCG, OGT | AKT1 3851/4885HPSE 165/4885FGF2 1156/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.